Addiction doctors have petitioned the US FDA to prevent Zohydro ER, the first single-entity hydrocodone painkiller, hitting the market this month citing its potential for abuse. Its maker, Zogenix, has been tight-lipped on whether the drug’s formulation...
Draft guidance issued by the US FDA suggests that greater use of inks, pigments, flavours and other physical chemical identifiers (PCIDs) will help combat counterfeit drugs.